In colon carcinomas, ANRIL overexpression was observed in invasive tumors (12%) compared to normal tissue (0%), and was higher in carcinomas at metastatic stage (16%) compared to locally invasive primary colon carcinomas (8%). Here, CDKN2B-AS1 is linked to carcinoma.